Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia

Background. Higher rate of gram-negative bloodstream infections (BSI) have been recently documented from transplantation centers providing fluoroquinolone (FQ) prophylaxis.Aim. To define the incidence of BSI during neutropenia according to gut mucosal colonization with resistant gramnegative bacteri...

Full description

Saved in:
Bibliographic Details
Main Authors: G. A. Klyasova, M. I. Akhmedov, L. A. Kuzmina, A. V. Fedorova, D. A. Mironova, E. N. Parovichnikova
Format: Article
Language:Russian
Published: ABV-press 2023-03-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/802
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409318843056128
author G. A. Klyasova
M. I. Akhmedov
L. A. Kuzmina
A. V. Fedorova
D. A. Mironova
E. N. Parovichnikova
author_facet G. A. Klyasova
M. I. Akhmedov
L. A. Kuzmina
A. V. Fedorova
D. A. Mironova
E. N. Parovichnikova
author_sort G. A. Klyasova
collection DOAJ
description Background. Higher rate of gram-negative bloodstream infections (BSI) have been recently documented from transplantation centers providing fluoroquinolone (FQ) prophylaxis.Aim. To define the incidence of BSI during neutropenia according to gut mucosal colonization with resistant gramnegative bacteria and FQ administration.Materials and methods. Of 284 allogeneic hematopoietic cell transplant recipients included in the study, 154 (54.2 %) were identified as colonized with resistant gram-negative bacteria, and 130 (45.8 %) patients as non-colonized. Resistant gram-negative bacteria included Enterobacterales with extended spectrum beta-lactamase production, carbapenem-resistant Enterobacterales, Stenotrophomonas maltophilia, and carbapenem-resistant strains of Pseudomonas aeruginosa. Colonized patients did not receive FQ prophylaxis (n = 147) except 7 patients who received FQ as sequential therapy due to residual inflammatory lung lesions. Among non-colonized patients 98 received FQ prophylaxis, whereas 32 did not.Results. Probability of gram-negative BSI (71.4 %; p <0.0001), and extended spectrum beta-lactamase-producing Enterobacterales BSI (57.1 %; p <0.0001) was significantly higher in colonized patients receiving FQ. No significant difference was found in probability of gram-positive BSI (p = 0.452). In multivariate analysis colonized patients with (hazard ratio (HR) 35.32; 95 % confidence interval (CI) 9.15–136.44; p <0.0001) or without FQ (HR 3.44; 95 % CI 1.15–10.31; p = 0.007), omission of FQ in non-colonized patients (HR 4.03; 95 % CI 1.08–15.00; p = 0.038), and active disease before allogeneic hematopoietic cell transplantation (HR 2.17; 95 % CI 1.03–4.63; p = 0.042) were associated with higher risk of gram-negative BSI, whereas mismatched unrelated donor transplantations were associated with higher gram-positive BSI risk (HR 3.84; 95 % CI 1.63–9.08; p = 0,009).Conclusion. Colonization with multiresistant gram-negative bacteria is a predictor of gram-negative BSI, including multiresistant pathogens, especially when FQ are prescribed during neutropenia, while in non-colonized patients FQ prophylaxis is an effective approach significantly reducing gram-negative BSI.
format Article
id doaj-art-61514f2e1254452ca9107f96925d2da2
institution Kabale University
issn 1818-8346
2413-4023
language Russian
publishDate 2023-03-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj-art-61514f2e1254452ca9107f96925d2da22025-08-20T03:35:33ZrusABV-pressОнкогематология1818-83462413-40232023-03-011818810010.17650/1818-8346-2023-18-1-88-100674Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropeniaG. A. Klyasova0M. I. Akhmedov1L. A. Kuzmina2A. V. Fedorova3D. A. Mironova4E. N. Parovichnikova5National Medical Research Center for Hematology, Ministry of Health of RussiaNational Medical Research Center for Hematology, Ministry of Health of RussiaNational Medical Research Center for Hematology, Ministry of Health of RussiaNational Medical Research Center for Hematology, Ministry of Health of RussiaNational Medical Research Center for Hematology, Ministry of Health of RussiaNational Medical Research Center for Hematology, Ministry of Health of RussiaBackground. Higher rate of gram-negative bloodstream infections (BSI) have been recently documented from transplantation centers providing fluoroquinolone (FQ) prophylaxis.Aim. To define the incidence of BSI during neutropenia according to gut mucosal colonization with resistant gramnegative bacteria and FQ administration.Materials and methods. Of 284 allogeneic hematopoietic cell transplant recipients included in the study, 154 (54.2 %) were identified as colonized with resistant gram-negative bacteria, and 130 (45.8 %) patients as non-colonized. Resistant gram-negative bacteria included Enterobacterales with extended spectrum beta-lactamase production, carbapenem-resistant Enterobacterales, Stenotrophomonas maltophilia, and carbapenem-resistant strains of Pseudomonas aeruginosa. Colonized patients did not receive FQ prophylaxis (n = 147) except 7 patients who received FQ as sequential therapy due to residual inflammatory lung lesions. Among non-colonized patients 98 received FQ prophylaxis, whereas 32 did not.Results. Probability of gram-negative BSI (71.4 %; p <0.0001), and extended spectrum beta-lactamase-producing Enterobacterales BSI (57.1 %; p <0.0001) was significantly higher in colonized patients receiving FQ. No significant difference was found in probability of gram-positive BSI (p = 0.452). In multivariate analysis colonized patients with (hazard ratio (HR) 35.32; 95 % confidence interval (CI) 9.15–136.44; p <0.0001) or without FQ (HR 3.44; 95 % CI 1.15–10.31; p = 0.007), omission of FQ in non-colonized patients (HR 4.03; 95 % CI 1.08–15.00; p = 0.038), and active disease before allogeneic hematopoietic cell transplantation (HR 2.17; 95 % CI 1.03–4.63; p = 0.042) were associated with higher risk of gram-negative BSI, whereas mismatched unrelated donor transplantations were associated with higher gram-positive BSI risk (HR 3.84; 95 % CI 1.63–9.08; p = 0,009).Conclusion. Colonization with multiresistant gram-negative bacteria is a predictor of gram-negative BSI, including multiresistant pathogens, especially when FQ are prescribed during neutropenia, while in non-colonized patients FQ prophylaxis is an effective approach significantly reducing gram-negative BSI.https://oncohematology.abvpress.ru/ongm/article/view/802bloodstream infectionsrecipientallogeneic hematopoietic stem cell transplantationmultiresistant gramnegative bacteriacolonizationfluoroquinolonesneutropenia
spellingShingle G. A. Klyasova
M. I. Akhmedov
L. A. Kuzmina
A. V. Fedorova
D. A. Mironova
E. N. Parovichnikova
Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia
Онкогематология
bloodstream infections
recipient
allogeneic hematopoietic stem cell transplantation
multiresistant gramnegative bacteria
colonization
fluoroquinolones
neutropenia
title Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia
title_full Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia
title_fullStr Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia
title_full_unstemmed Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia
title_short Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia
title_sort risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia
topic bloodstream infections
recipient
allogeneic hematopoietic stem cell transplantation
multiresistant gramnegative bacteria
colonization
fluoroquinolones
neutropenia
url https://oncohematology.abvpress.ru/ongm/article/view/802
work_keys_str_mv AT gaklyasova riskofbloodstreaminfectionsinallogeneichematopoieticcelltransplantrecipientsaccordingtogutmucosalcolonizationandfluoroquinoloneimplementationduringneutropenia
AT miakhmedov riskofbloodstreaminfectionsinallogeneichematopoieticcelltransplantrecipientsaccordingtogutmucosalcolonizationandfluoroquinoloneimplementationduringneutropenia
AT lakuzmina riskofbloodstreaminfectionsinallogeneichematopoieticcelltransplantrecipientsaccordingtogutmucosalcolonizationandfluoroquinoloneimplementationduringneutropenia
AT avfedorova riskofbloodstreaminfectionsinallogeneichematopoieticcelltransplantrecipientsaccordingtogutmucosalcolonizationandfluoroquinoloneimplementationduringneutropenia
AT damironova riskofbloodstreaminfectionsinallogeneichematopoieticcelltransplantrecipientsaccordingtogutmucosalcolonizationandfluoroquinoloneimplementationduringneutropenia
AT enparovichnikova riskofbloodstreaminfectionsinallogeneichematopoieticcelltransplantrecipientsaccordingtogutmucosalcolonizationandfluoroquinoloneimplementationduringneutropenia